معرفی
Kartik Chandran is a Professor and the Gertrude and David Feinson Chair in Medicine in the Department of Microbiology & Immunology at Albert Einstein College of Medicine. His research focuses on understanding the molecular mechanisms of viral entry and pathogenesis, particularly for emerging viruses such as Ebola, Marburg, and hantaviruses. He leads the Chandran Lab, which investigates viral-host interactions, antiviral therapies, and vaccine development.
Research Interests: Dr. Chandran’s work centers on filoviruses and bunyaviruses, with a focus on viral fusion glycoproteins, host receptors (e.g., NPC1), and the development of antibodies and small molecules to combat infections. His team has identified critical host factors enabling viral entry and explored genetic determinants of viral susceptibility.
Recent studies include antibody therapies against Crimean-Congo hemorrhagic fever, SARS-CoV-2 antigen design, and pan-filovirus protection strategies. The lab’s translational efforts aim to translate basic discoveries into clinical antivirals and vaccines.
Grants & Collaborations: Collaborations span institutions globally, including work on monkeypox immune responses and hantavirus vaccines. The lab actively recruits postdoctoral fellows for projects in viral pathogenesis and antiviral development.
Labs/Teams: The Chandran Lab is part of the Einstein’s Center for RNA Science and Therapeutics, emphasizing interdisciplinary research on viral RNA and host interactions.
